PropThink is an intelligence service that delivers long and short trading ideas to investors in the healthcare and life sciences sectors. As one of the leading online destinations for retail and institutional investors seeking actionable analysis of publicly-traded, emerging growth companies in the healthcare sector, the company focuses on identifying and analyzing technically complicated companies and equities that are grossly over- or under-valued. Their detailed analysis and due diligence process defines their editorial strategy and provides subscribers a high level of confidence in their research. PropThink’s editorial team is composed of individuals with a strong background in science, medicine, and the business of successfully commercializing therapeutics, medical devices, diagnostics and healthcare services. PropThink offers regular market coverage, actionable research, and a free weekly newsletter to investors subscribed on their website.
PropThink's ultimate objective is to leverage the knowledge and experience of their contributors to introduce subscribers to profitable long and short investment opportunities in the healthcare sector.
The company leverages a combined 50 years of experience in science, medicine, legal, regulatory affairs, finance, and operational industry experience to analyze companies at a highly technical level.
At present, PropThink offers regular market coverage and periodic feature specials (Insights), periodic Interviews with key opinion leaders and investors, and an actionable investing newsletter called PropThink Premium.